Albany's composites growth and strategic review progress offset weak textile demand and CFO uncertainty
Record Engineered Composites revenue and new business wins Albany's Engineered Composites segment hit a record $150.8 million in Q2 2026 revenue, up 16% on ramping LEAP, Boeing, and CH-53K programs. New wins like the Pratt & Whitney GTF contract support long-term growth, pushing the stock up on optimism about future sales.
This is the core positive driver showing strong demand in Albany's growth segment.
Strategic review completed, Utah facility retained, guidance raised Albany finished its review of the Salt Lake City plant and decided to keep it after securing new business, a renegotiated Boeing 787 contract, and better Sikorsky CH-53K terms. It raised Q3 adjusted EPS guidance to $1.40-$1.50 from $0.60-$0.70, signaling improved profitability and cash flow starting 2027.
This is a major new event that directly boosts earnings expectations and removes uncertainty.
Boeing 787 contract extended for composite frames Albany Engineered Composites agreed with Boeing to keep making about 300 unique composite fuselage frames for the 787 Dreamliner, a role held since 2014. This locks in steady demand for its composites segment, supporting revenue visibility and investor confidence.
This new contract extension secures future revenue and reinforces the positive demand trend.
CFO medical leave creates leadership uncertainty Albany's CFO Willard Station is on medical leave, and controller Sean Valashinas is acting CFO. Shares fell 4.82% on the news as investors worry about a gap in financial leadership, though the company moved quickly to fill the role temporarily.
This is a new negative event that weighs on the stock by adding uncertainty.